Tm Early Access Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article Share this article VANCOUVER, BC, Feb. 8, 2021 /PRNewswire/ - Chemistree Technology Inc. (CSE: CHM) (CSE: CHM.WT) (OTCQB: CHMJF) (the "Company" or "Chemistree") is pleased to inform shareholders that Chemistree investee ImmunoFlex™ has today announced that it is receiving advisory services and conditional research and development funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP). "ImmunoFlex is now recruiting patients into a Phase 4 clinical trial designed to optimize the impact of FLEX 20 TM on the immune system. The ...

Chemistree Investee ImmunoFlex Receives Health Canada Approval For Flex 10 Product News provided by Share this article Share this article VANCOUVER, BC, Jan. 19, 2021 /PRNewswire/ - Chemistree Technology Inc. (CSE: CHM) (CSE: CHM.wt) (USOTCQB: CHMJF) (the "Company" or "Chemistree") is pleased to inform shareholders that Chemistree investee company ImmunoFlex™, a life sciences company developing clinically validated, pharmaceutical grade natural health products based on advancements in genomics research, today announced the approval of FLEX 10™ by Health Canada. "At ImmunoFlex, we work wi...